{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05133531",
            "orgStudyIdInfo": {
                "id": "R3918-PNH-2021"
            },
            "secondaryIdInfos": [
                {
                    "id": "2020-004486-40",
                    "type": "EUDRACT_NUMBER"
                },
                {
                    "id": "2023-509657-31-00",
                    "type": "REGISTRY",
                    "domain": "EU CT Number"
                }
            ],
            "organization": {
                "fullName": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment",
            "officialTitle": "A Randomized, Open-Label, C5 Inhibitor-Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy",
            "acronym": "ACCESS-1",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-how-safe-pozelimab-cemdisiran-combination-therapy-is-and-how-well-it-works-in-adult-patients-with-paroxysmal-nocturnal-hemoglobinuria-pnh-who-have-not-recently-received-or-have-not-received-complement-inhibitor-treatment"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": true,
                "nctId": "NCT05232110",
                "statusForNctId": "AVAILABLE"
            },
            "startDateStruct": {
                "date": "2022-08-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-04-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-04-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-11-12",
            "studyFirstSubmitQcDate": "2021-11-12",
            "studyFirstPostDateStruct": {
                "date": "2021-11-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is researching a clinical treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on patients with paroxysmal nocturnal hemoglobinuria (PNH). The aim of the study is to see how safe and effective the pozelimab + cemdisiran combination is for patients with PNH and how the combination compares with 2 existing treatments, one called ravulizumab and the other called eculizumab.\n\nThe pozelimab + cemdisiran combination may be referred to as \"study drugs\". Ravulizumab and eculizumab may also be called the \"comparator drug\".\n\nThe study is looking at several research questions, including:\n\n* How effective is the pozelimab + cemdisiran combination compared to ravulizumab?\n* How effective is pozelimab + cemdisiran combination compared to eculizumab?\n* What side effects may happen from taking the study drugs?\n* How much study drugs are in the blood at different times?\n* Whether the body makes antibodies against the study drugs (which could make the study drugs less effective or could lead to side effects)"
        },
        "conditionsModule": {
            "conditions": [
                "Paroxysmal Nocturnal Hemoglobinuria"
            ],
            "keywords": [
                "PNH"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 190,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort A",
                    "type": "EXPERIMENTAL",
                    "description": "Randomized 1:1",
                    "interventionNames": [
                        "Drug: Ravulizumab",
                        "Drug: Pozelimab",
                        "Drug: Cemdisiran"
                    ]
                },
                {
                    "label": "Cohort B",
                    "type": "EXPERIMENTAL",
                    "description": "Randomized 1:1",
                    "interventionNames": [
                        "Drug: Pozelimab",
                        "Drug: Cemdisiran",
                        "Drug: Eculizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ravulizumab",
                    "description": "Administered Intravenous (IV) per the protocol",
                    "armGroupLabels": [
                        "Cohort A"
                    ],
                    "otherNames": [
                        "ALXN1210",
                        "Ultomiris"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pozelimab",
                    "description": "Administered IV and subcutaneous (SC) per the protocol",
                    "armGroupLabels": [
                        "Cohort A",
                        "Cohort B"
                    ],
                    "otherNames": [
                        "REGN3918"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cemdisiran",
                    "description": "Administered SC per the protocol",
                    "armGroupLabels": [
                        "Cohort A",
                        "Cohort B"
                    ],
                    "otherNames": [
                        "ALN-CC5"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Eculizumab",
                    "description": "Administered IV per the protocol",
                    "armGroupLabels": [
                        "Cohort B"
                    ],
                    "otherNames": [
                        "Soliris"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent change in lactate dehydrogenase (LDH)",
                    "description": "Cohort A",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Transfusion avoidance",
                    "description": "Cohort B Not requiring a red blood cell (RBC) transfusion per the protocol",
                    "timeFrame": "From post-baseline day 1 through week 26"
                },
                {
                    "measure": "Maintenance of adequate control of hemolysis",
                    "description": "Cohort B LDH \u22641.5 \u00d7 ULN",
                    "timeFrame": "From week 8 through week 26, inclusive"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Maintenance of adequate control of hemolysis",
                    "description": "Cohort A LDH \u22641.5 \u00d7 ULN",
                    "timeFrame": "From week 8 through week 26, inclusive"
                },
                {
                    "measure": "Breakthrough hemolysis",
                    "description": "Cohort A and B LDH \u22652 \u00d7 ULN per the protocol",
                    "timeFrame": "From post-baseline day 1 through week 26"
                },
                {
                    "measure": "Adequate control of hemolysis",
                    "description": "Cohort A and B LDH \u22641.5 \u00d7 ULN",
                    "timeFrame": "From week 8 through week 26, inclusive"
                },
                {
                    "measure": "Hemoglobin stabilization",
                    "description": "Cohort A and B Patients who do not receive an RBC transfusion and have no decrease in hemoglobin level per the protocol",
                    "timeFrame": "From day 1 (post-baseline) through week 26"
                },
                {
                    "measure": "Normalization of LDH",
                    "description": "Cohort A and B LDH \u22641.0 \u00d7 ULN per the protocol",
                    "timeFrame": "Between week 8 through week 26, inclusive"
                },
                {
                    "measure": "Transfusion avoidance",
                    "description": "Cohort A Not requiring an RBC transfusion as per protocol algorithm based on post-baseline hemoglobin values.",
                    "timeFrame": "Day 1 through week 26"
                },
                {
                    "measure": "Change in fatigue as measured by the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale",
                    "description": "Cohort A and B FACIT-Fatigue Scale is a 13-item, self-reported PRO measure assessing an individual's level of fatigue during their usual daily activities over the past week. This questionnaire is part of the FACIT measurement system, a compilation of questions measuring health-related quality of life (QoL) in patients with cancer and other chronic illnesses. The FACIT-fatigue assesses the level of fatigue using a Likert scale ranging from 0 (not at all) to 4 (very much). Scores range from 0 to 52, with higher scores indicating greater fatigue.",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Change in physical function (PF) scores on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30)",
                    "description": "Cohort A and B EORTC-QLQ-C30 is a 30-item subject self-report questionnaire composed of both multi-item and single scales, including global health status/quality of life, functional Scales (physical, role, emotional, cognitive, and social), symptom scales (fatigue, nausea and vomiting, and pain), and 7 single items (dyspnea, insomnia, appetite loss, constipation, diarrhea, sleep and financial difficulties). Participants rate items on a 4-point scale, with 1 as \"not at all\" and 4 as \"very much.\"",
                    "timeFrame": "Change from baseline to week 26"
                },
                {
                    "measure": "Change in global health status (GHS)/QoL scale score on the EORTC-QLC-C30",
                    "description": "Cohort A and B EORTC-QLQ-C30 is a 30-item subject self-report questionnaire composed of both multi-item and single scales, including global health status/quality of life, functional Scales (physical, role, emotional, cognitive, and social), symptom scales (fatigue, nausea and vomiting, and pain), and 7 single items (dyspnea, insomnia, appetite loss, constipation, diarrhea, sleep and financial difficulties). Participants rate items on a 4-point scale, with 1 as \"not at all\" and 4 as \"very much.\"",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Percent change in LDH",
                    "description": "Cohort B",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Rate of RBC transfused",
                    "description": "Cohort A and B Per protocol algorithm",
                    "timeFrame": "Post-baseline Day 1 through week 26"
                },
                {
                    "measure": "Number of units of RBC transfused",
                    "description": "Cohort A and B Per protocol algorithm",
                    "timeFrame": "Post-baseline Day 1 through week 26"
                },
                {
                    "measure": "Time to first LDH \u22641.5 \u00d7 ULN",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to Week 26"
                },
                {
                    "measure": "Time to first LDH \u22641.0 \u00d7 ULN",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to Week 26"
                },
                {
                    "measure": "Percentage of days with LDH \u22641.5 \u00d7 ULN",
                    "description": "Cohort A and B",
                    "timeFrame": "Between week 8 and week 26, inclusive"
                },
                {
                    "measure": "Change in hemoglobin levels",
                    "description": "Cohort A and B",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Incidence and severity of treatment emergent serious adverse events (SAEs)",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 26 weeks"
                },
                {
                    "measure": "Incidence and severity of treatment-emergent adverse events (TEAEs) of special interest",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 26 weeks"
                },
                {
                    "measure": "Incidence and severity of TEAEs leading to treatment discontinuation",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 26 weeks"
                },
                {
                    "measure": "Change in total CH50",
                    "description": "Cohort A and B",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Percent change in total CH50",
                    "description": "Cohort A and B",
                    "timeFrame": "From baseline to week 26"
                },
                {
                    "measure": "Concentration of total C5 in plasma",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 60 weeks"
                },
                {
                    "measure": "Concentrations of total pozelimab in serum",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 60 weeks"
                },
                {
                    "measure": "Concentrations of cemdisiran in plasma",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 60 weeks"
                },
                {
                    "measure": "Concentrations of total ravulizumab in serum",
                    "description": "Cohort A",
                    "timeFrame": "Up to 34 weeks"
                },
                {
                    "measure": "Concentrations of total eculizumab in serum",
                    "description": "Cohort B",
                    "timeFrame": "Up to 30 weeks"
                },
                {
                    "measure": "Incidence of treatment emergent anti-drug antibodies (ADAs) to pozelimab",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 60 weeks"
                },
                {
                    "measure": "Incidence of treatment emergent ADAs to cemdisiran",
                    "description": "Cohort A and B",
                    "timeFrame": "Up to 60 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. Diagnosis of PNH confirmed by high-sensitivity flow cytometry testing with PNH granulocytes or monocytes as described in the protocol\n2. Active disease, as defined by the presence of 1 or more PNH-related signs or symptoms as described in the protocol\n3. LDH level \u22652 \u00d7 ULN at the screening visit\n4. Willing and able to comply with clinic/remote visits and study-related procedures, including completion of the full series of meningococcal vaccinations required per protocol\n\nKey Exclusion Criteria:\n\n1. Prior treatment with eculizumab within 3 months prior to screening, ravulizumab within 6 months prior to screening, or other complement inhibitors within 5 half-lives of the respective agent prior to screening\n2. Receipt of an organ transplant, history of bone marrow transplantation or other hematologic transplant\n3. Body weight \\<40 kilograms at screening visit\n4. Planned use of any complement inhibitor therapy other than study drugs during the treatment period\n5. Not meeting meningococcal vaccination requirements and, at a minimum documentation of quadrivalent meningococcal vaccination within 5 years prior to the screening visit and serotype B vaccine within 3 years prior to the screening visit as described in the protocol.\n6. Any contraindication for receiving Neisseria meningitidis vaccinations (serotypes ACWY and B).\n7. Unable to take antibiotics for meningococcal prophylaxis (if required by local ravulizumab \\[Cohort A\\] or eculizumab \\[Cohort B\\] prescribing information, where available, or national guidelines/local practice, or if necessary when administration of the first dose of the vaccination is less than 2 weeks prior to study treatment initiation)\n8. Any active, ongoing infection or a recent infection requiring ongoing systemic treatment with antibiotics, antivirals, or antifungals within 2 weeks of screening or during the screening period\n9. Documented history of active, uncontrolled, ongoing systemic autoimmune diseases\n\nNote: Other protocol-defined Inclusion/ Exclusion Criteria apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Administrator",
                    "role": "CONTACT",
                    "phone": "844-734-6643",
                    "email": "clinicaltrials@regeneron.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trial Management",
                    "affiliation": "Regeneron Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Oncology Institute of Hope and Innovation",
                    "status": "RECRUITING",
                    "city": "Whittier",
                    "state": "California",
                    "zip": "90603",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.97918,
                        "lon": -118.03284
                    }
                },
                {
                    "facility": "Toronto General Hospital",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2C4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "George Papanikolaou Hospital",
                    "status": "RECRUITING",
                    "city": "Thessaloniki",
                    "zip": "570 10",
                    "country": "Greece",
                    "geoPoint": {
                        "lat": 40.64361,
                        "lon": 22.93086
                    }
                },
                {
                    "facility": "Semmelweis Egyetem",
                    "status": "RECRUITING",
                    "city": "Budapest",
                    "zip": "1089",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.49801,
                        "lon": 19.03991
                    }
                },
                {
                    "facility": "Fondazione Policlinico Universitario A Gemelli",
                    "status": "RECRUITING",
                    "city": "Roma",
                    "state": "Lazio",
                    "zip": "168",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Citt\u00c3 della Salute e della Scienza di Torino",
                    "status": "RECRUITING",
                    "city": "Torino",
                    "state": "Piemonte",
                    "zip": "10126",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.07049,
                        "lon": 7.68682
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Universitaria Careggi",
                    "status": "RECRUITING",
                    "city": "Firenze",
                    "zip": "50134",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.77925,
                        "lon": 11.24626
                    }
                },
                {
                    "facility": "Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital",
                    "status": "RECRUITING",
                    "city": "Nagoya",
                    "state": "Aichi",
                    "zip": "466-8650",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.18147,
                        "lon": 136.90641
                    }
                },
                {
                    "facility": "Ogaki Municipal Hospital",
                    "status": "RECRUITING",
                    "city": "Ogaki city",
                    "state": "Gifu",
                    "zip": "503-8502",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.35,
                        "lon": 136.61667
                    }
                },
                {
                    "facility": "University of Tsukuba Hospital",
                    "status": "RECRUITING",
                    "city": "Tsukuba-shi",
                    "state": "Ibaraki",
                    "zip": "305-8576",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 36.2,
                        "lon": 140.1
                    }
                },
                {
                    "facility": "Panasonic Health Insurance Organization Matsushita Memorial Hospital",
                    "status": "RECRUITING",
                    "city": "Moriguchi-city",
                    "state": "Osaka",
                    "zip": "570-8540",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.73333,
                        "lon": 135.56667
                    }
                },
                {
                    "facility": "NTT Medical Center Tokyo",
                    "status": "RECRUITING",
                    "city": "Shinagawa-ku",
                    "state": "Tokyo",
                    "zip": "141-8625",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.63627,
                        "lon": 133.00572
                    }
                },
                {
                    "facility": "Pusan National University Hospital",
                    "status": "RECRUITING",
                    "city": "Busan",
                    "zip": "49241",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.10278,
                        "lon": 129.04028
                    }
                },
                {
                    "facility": "Ajou University Medical Center",
                    "status": "RECRUITING",
                    "city": "Gyeonggi-do",
                    "zip": "16499",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.58944,
                        "lon": 126.76917
                    }
                },
                {
                    "facility": "Gachon University Gil Medical Center",
                    "status": "RECRUITING",
                    "city": "Incheon",
                    "zip": "21565",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.45646,
                        "lon": 126.70515
                    }
                },
                {
                    "facility": "Korea University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "02841",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center - PPDS",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Ewha Womans University Mokdong Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "7895",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "St. Vincent Hospital",
                    "status": "RECRUITING",
                    "city": "Suwon",
                    "zip": "16247",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.29111,
                        "lon": 127.00889
                    }
                },
                {
                    "facility": "Hospital Tengku Ampuan Afzan",
                    "status": "RECRUITING",
                    "city": "Kuantan",
                    "state": "Pahang",
                    "zip": "25200",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 3.8077,
                        "lon": 103.326
                    }
                },
                {
                    "facility": "Hospital Ampang",
                    "status": "RECRUITING",
                    "city": "Ampang",
                    "state": "Selangor",
                    "zip": "68000",
                    "country": "Malaysia"
                },
                {
                    "facility": "Queen Elizabeth Hospital - Kota Kinabalu",
                    "status": "RECRUITING",
                    "city": "Kota Kinabalu",
                    "zip": "88586",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 5.9749,
                        "lon": 116.0724
                    }
                },
                {
                    "facility": "Hospital Universitario Dr. Jose Eleuterio Gonz\u00e1lez",
                    "status": "RECRUITING",
                    "city": "Monterrey",
                    "state": "Nuevo Le\u00f3n",
                    "zip": "64460",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 25.67507,
                        "lon": -100.31847
                    }
                },
                {
                    "facility": "Klinika Hematologii, Szpital Uniwersytecki Nr 2 im. Jana Biziela w Bydgoszczy",
                    "status": "RECRUITING",
                    "city": "Bydgoszcz",
                    "zip": "85-168",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.1235,
                        "lon": 18.00762
                    }
                },
                {
                    "facility": "Uniwersyteckie Centrum Kliniczne",
                    "status": "RECRUITING",
                    "city": "Gdansk",
                    "zip": "80-214",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 54.35205,
                        "lon": 18.64637
                    }
                },
                {
                    "facility": "Instytut Hematologii i Transfuzjologii",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "02-776",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Prof Dr I Chiricuta Institute of Oncology",
                    "status": "RECRUITING",
                    "city": "Cluj-Napoca",
                    "state": "Cluj",
                    "zip": "400015",
                    "country": "Romania",
                    "geoPoint": {
                        "lat": 46.76667,
                        "lon": 23.6
                    }
                },
                {
                    "facility": "Filantropia Municipal Clinical Hospital",
                    "status": "RECRUITING",
                    "city": "Craiova",
                    "state": "Dolj",
                    "zip": "200143",
                    "country": "Romania",
                    "geoPoint": {
                        "lat": 44.31667,
                        "lon": 23.8
                    }
                },
                {
                    "facility": "Targu-Mures Emergency Clinical County Hospital",
                    "status": "RECRUITING",
                    "city": "Targu Mures",
                    "state": "Mures",
                    "zip": "540136",
                    "country": "Romania",
                    "geoPoint": {
                        "lat": 46.54245,
                        "lon": 24.55747
                    }
                },
                {
                    "facility": "National University Hospital",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "zip": "119074",
                    "country": "Singapore",
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "Hospital Universitario Basurto",
                    "status": "RECRUITING",
                    "city": "Bilbao",
                    "state": "Vizcaya",
                    "zip": "48013",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 43.26271,
                        "lon": -2.92528
                    }
                },
                {
                    "facility": "Hospital Clinic de Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "8036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Changhua Christian Hospital",
                    "status": "RECRUITING",
                    "city": "Changhua City",
                    "zip": "50006",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.07327,
                        "lon": 120.56276
                    }
                },
                {
                    "facility": "Hualien Tzu Chi Hospital",
                    "status": "RECRUITING",
                    "city": "Hualien City",
                    "zip": "97002",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 23.97694,
                        "lon": 121.60444
                    }
                },
                {
                    "facility": "Kaohsiung Medical University - Chung-Ho Memorial Hospital",
                    "status": "RECRUITING",
                    "city": "Kaohsiung",
                    "zip": "807",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "China Medical University Hospital - PPDS",
                    "status": "RECRUITING",
                    "city": "Taichung",
                    "zip": "40447",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Tri-Service General Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "11490",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Chang Gung Hospital",
                    "status": "RECRUITING",
                    "city": "Taoyuan City",
                    "zip": "33305",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "RECRUITING",
                    "city": "Tapei City",
                    "zip": "100229",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Rajavithi Hospital",
                    "status": "WITHDRAWN",
                    "city": "Ratchathewi",
                    "state": "Krung Thep Maha Nakhon-Bangkok",
                    "zip": "10400",
                    "country": "Thailand",
                    "geoPoint": {
                        "lat": 13.759,
                        "lon": 100.53358
                    }
                },
                {
                    "facility": "Songklanagarind Hospital Prince of Songkla University",
                    "status": "RECRUITING",
                    "city": "Hat Yai",
                    "state": "Songkhla",
                    "zip": "90110",
                    "country": "Thailand",
                    "geoPoint": {
                        "lat": 7.00836,
                        "lon": 100.47668
                    }
                },
                {
                    "facility": "King Chulalongkorn Memorial Hospital",
                    "status": "RECRUITING",
                    "city": "Bangkok",
                    "zip": "10330",
                    "country": "Thailand",
                    "geoPoint": {
                        "lat": 13.75398,
                        "lon": 100.50144
                    }
                },
                {
                    "facility": "Chiang Mai University",
                    "status": "RECRUITING",
                    "city": "Chiang Mai",
                    "zip": "50200",
                    "country": "Thailand",
                    "geoPoint": {
                        "lat": 18.79038,
                        "lon": 98.98468
                    }
                },
                {
                    "facility": "Srinagarind Hospital",
                    "status": "RECRUITING",
                    "city": "Khon Kaen",
                    "zip": "40000",
                    "country": "Thailand",
                    "geoPoint": {
                        "lat": 16.44671,
                        "lon": 102.833
                    }
                },
                {
                    "facility": "Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34418",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Ege Universitesi Tip Fakultesi Hastanesi",
                    "status": "RECRUITING",
                    "city": "Izmir",
                    "zip": "35100",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 38.41273,
                        "lon": 27.13838
                    }
                },
                {
                    "facility": "St James University Hospital",
                    "status": "RECRUITING",
                    "city": "Leeds",
                    "zip": "LS9 7TF",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.79648,
                        "lon": -1.54785
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "All Individual Patient Data (IPD) that underlie publicly available results will be considered for sharing",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "When Regeneron has received marketing authorization from major health authorities (e.g., FDA, European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA), etc.) for the product and indication, has made the study results publicly available (e.g., scientific publication, scientific conference, clinical trial registry), has the legal authority to share the data, and has ensured the ability to protect participant privacy.",
            "accessCriteria": "Qualified researchers can submit a proposal for access to individual patient or aggregate level data from a Regeneron-sponsored clinical trial through Vivli. Regeneron's Independent Research Request Evaluation Criteria can be found at: https://www.regeneron.com/sites/default/files/Regeneron-External-Data-Sharing-Policy-and-Independent-Research-Request-Evaluation-Criteria.pdf",
            "url": "https://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006456",
                    "term": "Hemoglobinuria"
                },
                {
                    "id": "D000006457",
                    "term": "Hemoglobinuria, Paroxysmal"
                }
            ],
            "ancestors": [
                {
                    "id": "D000011507",
                    "term": "Proteinuria"
                },
                {
                    "id": "D000014555",
                    "term": "Urination Disorders"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000020924",
                    "term": "Urological Manifestations"
                },
                {
                    "id": "D000000743",
                    "term": "Anemia, Hemolytic"
                },
                {
                    "id": "D000000740",
                    "term": "Anemia"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000009190",
                    "term": "Myelodysplastic Syndromes"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9542",
                    "name": "Hemoglobinuria",
                    "asFound": "Hemoglobinuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9543",
                    "name": "Hemoglobinuria, Paroxysmal",
                    "asFound": "Paroxysmal Nocturnal Hemoglobinuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14368",
                    "name": "Proteinuria",
                    "relevance": "LOW"
                },
                {
                    "id": "M17305",
                    "name": "Urination Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22659",
                    "name": "Urological Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M4070",
                    "name": "Anemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M9547",
                    "name": "Hemolysis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4073",
                    "name": "Anemia, Hemolytic",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M14164",
                    "name": "Preleukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12145",
                    "name": "Myelodysplastic Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4436",
                    "name": "Paroxysmal Nocturnal Hemoglobinuria",
                    "asFound": "Paroxysmal Nocturnal Hemoglobinuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3993",
                    "name": "Myelodysplastic Syndromes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000481642",
                    "term": "Eculizumab"
                },
                {
                    "id": "C000629409",
                    "term": "Ravulizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000051056",
                    "term": "Complement Inactivating Agents"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6392",
                    "name": "Complement System Proteins",
                    "relevance": "LOW"
                },
                {
                    "id": "M350841",
                    "name": "Eculizumab",
                    "asFound": "Pts",
                    "relevance": "HIGH"
                },
                {
                    "id": "M287455",
                    "name": "Ravulizumab",
                    "asFound": "CCT",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}